(Q36590745)

15 August 2017

1 reference

title

Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature (English)

1 reference

15 August 2017

1 reference

Marie I

1

1 reference

15 August 2017

Maurey G

2

1 reference

15 August 2017

Hervé F

3

1 reference

15 August 2017

Hellot MF

4

1 reference

15 August 2017

Levesque H

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

British Journal of Dermatology

15 August 2017

published in

1 reference

15 August 2017

volume

155

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

714-721

1 reference

5th International symposium on IVIG: IVIG in the third millenium, 25-27 September 2003, Interlaken, Switzerland

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Complications of intravenous immune globulin treatment in neurologic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Complications of intravenous immune globulin treatment in neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Thrombotic complications after intravenous immunoglobulin therapy in two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Therapy with Intravenous Immunoglobulins: Complications and Side-Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Acute renal insufficiency and cerebral infarction during high-dose intravenous immunoglobulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk-benefit assessment for immunoglobulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Venous and arterial thrombosis following administration of intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Thromboembolic complications of intravenous immunoglobulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

High-Dose Corticosteroid Treatment Is Associated with an Increased Risk of Developing Cerebral Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Effect of high-dose intravenous immunoglobulin therapy on blood rheology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Intravenous immunoglobulin therapy results in post‐infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

Intravenous immunoglobulin treatment of neurological autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07390.X

10.1111/J.1365-2133.2006.07390.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference